Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia
Cognitive impairment is strongly associated with functional outcome in patients with schizophrenia but its pathophysiology remains largely unclear. Involvement of omega-3 fatty acids in the cognitive function of healthy individuals and patients with neuropsychiatric disease has received increasing a...
Main Authors: | Kazumi Satogami, Shun Takahashi, Shinichi Yamada, Satoshi Ukai, Kazuhiro Shinosaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Schizophrenia Research: Cognition |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2215001317300045 |
Similar Items
-
Nutritional assessment of omega-3 fatty acids intake in schizophrenia patients group
by: Rog Joanna, et al.
Published: (2019-06-01) -
Omega-3 fatty acids in schizophrenia Part II: Clinical applications
by: Róg Joanna, et al.
Published: (2016-12-01) -
Omega – 3 fatty acids in schizophrenia – part I: importance in the pathophysiology of schizophrenia
by: Róg Joanna, et al.
Published: (2016-09-01) -
Omega 3 fatty acids in psychiatry
by: Pavlović D.M., et al.
Published: (2013-01-01) -
Ácidos graxos ômega 3 e tratamento da esquizofrenia Omega 3 fatty acid and schizophrenia treatment
by: Juliane Costa Silva Zemdegs, et al.
Published: (2010-01-01)